Moderna and Merck’s Melanoma Breakthrough | Rochester News

Moderna and Merck just dropped some major news on melanoma treatment—early trial results show a custom mRNA vaccine, paired with Keytruda, slashed the risk of death by nearly half for advanced-stage patients. This isn’t your average therapy: scientists sequence your tumor’s DNA, design a personalized vaccine to train your immune system to hunt down cancer cells, and it’s already showing life-changing promise. Not FDA-approved yet, but doctors are calling it a potential game-changer for those who’ve run out of options. Side effects and cost remain unknown—but when you’re talking about turning the tide on deadly skin cancer? This is exactly the kind of innovation we need. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/cf38306461d9769d